Vapotherm (NYSE:VAPO) Sets New 52-Week High at $40.97
Vapotherm Inc (NYSE:VAPO) reached a new 52-week high during trading on Tuesday . The company traded as high as $40.97 and last traded at $40.85, with a volume of 40628 shares trading hands. The stock had previously closed at $39.01.
A number of research analysts have recently commented on the stock. Zacks Investment Research downgraded shares of Vapotherm from a “buy” rating to a “hold” rating in a research note on Thursday, June 18th. Canaccord Genuity upped their price objective on shares of Vapotherm from $30.00 to $34.00 and gave the company a “buy” rating in a research note on Friday, June 5th. BTIG Research reiterated a “buy” rating and set a $32.00 target price on shares of Vapotherm in a report on Tuesday, May 26th. ValuEngine cut Vapotherm from a “buy” rating to a “hold” rating in a report on Monday, March 30th. Finally, William Blair reiterated an “outperform” rating on shares of Vapotherm in a report on Thursday, March 5th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Vapotherm currently has a consensus rating of “Buy” and an average price target of $35.00.
The company has a debt-to-equity ratio of 1.01, a current ratio of 3.99 and a quick ratio of 3.56. The company has a 50-day simple moving average of $30.58 and a two-hundred day simple moving average of $17.69. The stock has a market capitalization of $856.88 million, a price-to-earnings ratio of -15.62 and a beta of -1.54.
Institutional investors and hedge funds have recently bought and sold shares of the company. HighMark Wealth Management LLC grew its holdings in shares of Vapotherm by 50.0% during the 1st quarter. HighMark Wealth Management LLC now owns 1,500 shares of the company’s stock worth $28,000 after purchasing an additional 500 shares in the last quarter. Citigroup Inc. raised its position in Vapotherm by 241.6% in the 4th quarter. Citigroup Inc. now owns 3,047 shares of the company’s stock valued at $37,000 after purchasing an additional 2,155 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in Vapotherm in the 1st quarter valued at $43,000. BNP Paribas Arbitrage SA raised its position in Vapotherm by 118.7% in the 1st quarter. BNP Paribas Arbitrage SA now owns 4,645 shares of the company’s stock valued at $87,000 after purchasing an additional 2,521 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in Vapotherm in the 1st quarter valued at $107,000. 57.59% of the stock is owned by institutional investors.
About Vapotherm (NYSE:VAPO)
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Read More: Futures Contract
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.